Cancer patients with anorexia and weight loss research hub

A trial of the synthetic cannabinoid ART27.13 to stimulate appetite in patients with cancer anorexia and weight loss

This clinical trial is testing a new medicine called ART27.13 to see if it can help improve appetite and prevent weight loss in people with cancer. Researchers want to find the safest, most effective dose and see if it helps patients regain muscle and body weight.